Evaluation of the Effects of a Novel Nicotinic Agonist, AZD1446, on Neurochemical and Electrophysiologic Endpoints in DYT1 Mouse Models.

Grant

Date/time Interval

  • May 1, 2015 - October 31, 2016
  • Total Award Amount

  • 50000.00
  • Direct Costs

  • 50000.00
  • Sponsor Award Id

  • Contributor

  • Standaert, David   Principal Investigator